Entry |
|
Symbol |
PIK3CB, P110BETA, PI3K, PI3KBETA, PIK3C1
|
Name |
(RefSeq) phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta
|
KO |
K00922 | phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha/beta/delta [EC:2.7.1.153] |
|
Organism |
|
Pathway |
hsa01521 | EGFR tyrosine kinase inhibitor resistance |
hsa04070 | Phosphatidylinositol signaling system |
hsa04072 | Phospholipase D signaling pathway |
hsa04213 | Longevity regulating pathway - multiple species |
hsa04550 | Signaling pathways regulating pluripotency of stem cells |
hsa04613 | Neutrophil extracellular trap formation |
hsa04620 | Toll-like receptor signaling pathway |
hsa04625 | C-type lectin receptor signaling pathway |
hsa04650 | Natural killer cell mediated cytotoxicity |
hsa04660 | T cell receptor signaling pathway |
hsa04662 | B cell receptor signaling pathway |
hsa04664 | Fc epsilon RI signaling pathway |
hsa04666 | Fc gamma R-mediated phagocytosis |
hsa04670 | Leukocyte transendothelial migration |
hsa04750 | Inflammatory mediator regulation of TRP channels |
hsa04810 | Regulation of actin cytoskeleton |
hsa04914 | Progesterone-mediated oocyte maturation |
hsa04919 | Thyroid hormone signaling pathway |
hsa04923 | Regulation of lipolysis in adipocytes |
hsa04932 | Non-alcoholic fatty liver disease |
hsa04933 | AGE-RAGE signaling pathway in diabetic complications |
hsa04935 | Growth hormone synthesis, secretion and action |
hsa04960 | Aldosterone-regulated sodium reabsorption |
hsa04973 | Carbohydrate digestion and absorption |
hsa05100 | Bacterial invasion of epithelial cells |
hsa05163 | Human cytomegalovirus infection |
hsa05166 | Human T-cell leukemia virus 1 infection |
hsa05167 | Kaposi sarcoma-associated herpesvirus infection |
hsa05168 | Herpes simplex virus 1 infection |
hsa05170 | Human immunodeficiency virus 1 infection |
hsa05207 | Chemical carcinogenesis - receptor activation |
hsa05208 | Chemical carcinogenesis - reactive oxygen species |
hsa05230 | Central carbon metabolism in cancer |
hsa05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer |
hsa05418 | Fluid shear stress and atherosclerosis |
|
Network |
|
Element |
N00030 | EGF-EGFR-RAS-PI3K signaling pathway |
N00031 | Duplication or mutation-activated FLT3 to RAS-PI3K signaling pathway |
N00032 | Mutation-activated KRAS/NRAS to PI3K signaling pathway |
N00033 | EGF-EGFR-PI3K signaling pathway |
N00034 | ERBB2-overexpression to PI3K signaling pathway |
N00035 | Amplified EGFR to PI3K signaling pathway |
N00036 | Mutation-activated EGFR to PI3K signaling pathway |
N00037 | FGF-FGFR-PI3K signaling pathway |
N00038 | Amplified FGFR to PI3K signaling pathway |
N00039 | PDGF-PDGFR-PI3K signaling pathway |
N00040 | Amplified PDGFR to PI3K signaling pathway |
N00042 | EGFR-overexpression to PI3K signaling pathway |
N00043 | HGF-MET-PI3K signaling pathway |
N00044 | Mutation-activated MET to PI3K signaling pathway |
N00045 | KITLG-KIT-PI3K signaling pathway |
N00046 | Mutation-activated KIT to PI3K signaling pathway |
N00047 | EML4-ALK fusion kinase to PI3K signaling pathway |
N00048 | BCR-ABL fusion kinase to PI3K signaling pathway |
N00159 | KSHV K1 to PI3K signaling pathway |
N00179 | KSHV K1 to PI3K-NFKB signaling pathway |
N00182 | IGF-IGFR-PI3K-NFKB signaling pathway |
N00218 | FLT3LG-FLT3-RAS-PI3K signaling pathway |
N00231 | TGFA-EGFR-PI3K signaling pathway |
N00232 | TGFA-overexpression to PI3K signaling pathway |
N00234 | IGF2-IGF1R-PI3K signaling pathway |
N00236 | IGF2-overexpression to PI3K signaling pathway |
N00238 | IGF1R-overexpression to PI3K signaling pathway |
N00247 | HGF-overexpression to PI3K signaling pathway |
N00249 | MET-overexpression to PI3K signaling pathway |
N00253 | Amplified ERBB2 to PI3K signaling pathway |
N00260 | Amplified MET to PI3K signaling pathway |
N00266 | EBV LMP2A to PI3K signaling pathway |
N00267 | HBV HBx to PI3K signaling pathway |
N00272 | HCV NS5A to PI3K signaling pathway |
N00281 | EGF-overexpression to PI3K signaling pathway |
N00282 | EREG-EGFR-PI3K signaling pathway |
N00283 | EREG-overexpression to PI3K signaling pathway |
N00284 | AREG-EGFR-PI3K signaling pathway |
N00285 | AREG-overexpression to PI3K signaling pathway |
N00387 | HCMV IE1-72/IE2-86 to PI3K signaling pathway |
N00390 | EGF-EGFR-PI3K-NFKB signaling pathway |
N00399 | CCR2-GNB/G-PI3K-NFKB signaling pathway |
N00430 | CXCR4-GNAI-PI3K-BAD signaling pathway |
N00485 | EBV LMP1 to PI3K signaling pathway |
N00501 | HTLV-1 Tax to EGFR-PI3K-NFKB signaling pathway |
N00514 | Mutation-activated EGFR to PI3K signaling pathway |
N00582 | IGF-IGF1R-PI3K signaling pathway |
N00583 | HSV VP11/12 to PI3K signaling pathway |
N00683 | CD80/CD86-CD28-PI3K signaling pathway |
N00684 | MV F/H to CD28-PI3K signaling pathway |
N00736 | IAV NS1 to PI3K signaling pathway |
N00963 | RELN-VLDLR-PI3K signaling pathway |
N00964 | DAB1-overexpression to RELN-VLDLR-PI3K signaling pathway |
N01063 | Mutation-activated MET to PI3K signaling pathway |
N01065 | Mutation-activated RET to PI3K signaling pathway |
N01067 | Shigella IpgD to ARNO-ARF-ACTB_G signaling pathway |
N01129 | Salmonella SopB to ARNO-ARF-ACTB/G signaling pathway |
N01163 | NRG-ERBB4-PI3K signaling pathway |
N01204 | PRNP-PI3K-NOX2 signaling pathway |
N01205 | Scrapie conformation PrPSc to PRNP-PI3K-NOX2 signaling pathway |
N01338 | ACH-CHRN-PI3K signaling pathway |
N01339 | NNK/NNN to PI3K signaling pathway |
N01347 | EP/NE-ADRB-PI3K signaling pathway |
N01348 | Nicotine/NNK to PI3K signaling pathway |
N01349 | ACH-CHRN-PI3K signaling pathway |
N01350 | NNK/NNN to PI3K signaling pathway |
N01355 | Arsenic to PI3K signaling pathway |
N01356 | Membrane-initiated progesterone signaling pathway |
N01357 | P4/MPA to membrane-initiated progesterone signaling pathway |
N01358 | P4-PR-PI3K signaling pathway |
N01359 | P4/MPA to PR-PI3K signaling pathway |
N01656 | GF-RTK-PI3K signaling pathway |
N01658 | GF-RTK-RAS-PI3K signaling pathway |
N01708 | INS-AKT signaling pathway |
N01770 | CCR2-GNB/G-PI3K signaling pathway |
N01858 | EFNB1-MAPT axon guidance signaling |
N01875 | NRG-ERBB2/ERBB3 pathway (P13K signaling) |
|
Drug target |
|
Brite |
KEGG Orthology (KO) [BR:hsa00001]
09100 Metabolism
09101 Carbohydrate metabolism
00562 Inositol phosphate metabolism
5291 (PIK3CB)
09130 Environmental Information Processing
09132 Signal transduction
04012 ErbB signaling pathway
5291 (PIK3CB)
04014 Ras signaling pathway
5291 (PIK3CB)
04015 Rap1 signaling pathway
5291 (PIK3CB)
04370 VEGF signaling pathway
5291 (PIK3CB)
04630 JAK-STAT signaling pathway
5291 (PIK3CB)
04668 TNF signaling pathway
5291 (PIK3CB)
04066 HIF-1 signaling pathway
5291 (PIK3CB)
04068 FoxO signaling pathway
5291 (PIK3CB)
04070 Phosphatidylinositol signaling system
5291 (PIK3CB)
04072 Phospholipase D signaling pathway
5291 (PIK3CB)
04071 Sphingolipid signaling pathway
5291 (PIK3CB)
04024 cAMP signaling pathway
5291 (PIK3CB)
04151 PI3K-Akt signaling pathway
5291 (PIK3CB)
04152 AMPK signaling pathway
5291 (PIK3CB)
04150 mTOR signaling pathway
5291 (PIK3CB)
09133 Signaling molecules and interaction
04081 Hormone signaling
5291 (PIK3CB)
09140 Cellular Processes
09141 Transport and catabolism
04140 Autophagy - animal
5291 (PIK3CB)
09143 Cell growth and death
04210 Apoptosis
5291 (PIK3CB)
04218 Cellular senescence
5291 (PIK3CB)
09144 Cellular community - eukaryotes
04510 Focal adhesion
5291 (PIK3CB)
04550 Signaling pathways regulating pluripotency of stem cells
5291 (PIK3CB)
09142 Cell motility
04810 Regulation of actin cytoskeleton
5291 (PIK3CB)
09150 Organismal Systems
09151 Immune system
04611 Platelet activation
5291 (PIK3CB)
04613 Neutrophil extracellular trap formation
5291 (PIK3CB)
04620 Toll-like receptor signaling pathway
5291 (PIK3CB)
04625 C-type lectin receptor signaling pathway
5291 (PIK3CB)
04650 Natural killer cell mediated cytotoxicity
5291 (PIK3CB)
04660 T cell receptor signaling pathway
5291 (PIK3CB)
04662 B cell receptor signaling pathway
5291 (PIK3CB)
04664 Fc epsilon RI signaling pathway
5291 (PIK3CB)
04666 Fc gamma R-mediated phagocytosis
5291 (PIK3CB)
04670 Leukocyte transendothelial migration
5291 (PIK3CB)
04062 Chemokine signaling pathway
5291 (PIK3CB)
09152 Endocrine system
04910 Insulin signaling pathway
5291 (PIK3CB)
04923 Regulation of lipolysis in adipocytes
5291 (PIK3CB)
04929 GnRH secretion
5291 (PIK3CB)
04915 Estrogen signaling pathway
5291 (PIK3CB)
04914 Progesterone-mediated oocyte maturation
5291 (PIK3CB)
04917 Prolactin signaling pathway
5291 (PIK3CB)
04926 Relaxin signaling pathway
5291 (PIK3CB)
04935 Growth hormone synthesis, secretion and action
5291 (PIK3CB)
04919 Thyroid hormone signaling pathway
5291 (PIK3CB)
09154 Digestive system
04973 Carbohydrate digestion and absorption
5291 (PIK3CB)
09155 Excretory system
04960 Aldosterone-regulated sodium reabsorption
5291 (PIK3CB)
09156 Nervous system
04725 Cholinergic synapse
5291 (PIK3CB)
04722 Neurotrophin signaling pathway
5291 (PIK3CB)
09157 Sensory system
04750 Inflammatory mediator regulation of TRP channels
5291 (PIK3CB)
09158 Development and regeneration
04360 Axon guidance
5291 (PIK3CB)
04380 Osteoclast differentiation
5291 (PIK3CB)
09149 Aging
04211 Longevity regulating pathway
5291 (PIK3CB)
04213 Longevity regulating pathway - multiple species
5291 (PIK3CB)
09160 Human Diseases
09161 Cancer: overview
05200 Pathways in cancer
5291 (PIK3CB)
05206 MicroRNAs in cancer
5291 (PIK3CB)
05205 Proteoglycans in cancer
5291 (PIK3CB)
05207 Chemical carcinogenesis - receptor activation
5291 (PIK3CB)
05208 Chemical carcinogenesis - reactive oxygen species
5291 (PIK3CB)
05203 Viral carcinogenesis
5291 (PIK3CB)
05230 Central carbon metabolism in cancer
5291 (PIK3CB)
05231 Choline metabolism in cancer
5291 (PIK3CB)
05235 PD-L1 expression and PD-1 checkpoint pathway in cancer
5291 (PIK3CB)
09162 Cancer: specific types
05210 Colorectal cancer
5291 (PIK3CB)
05212 Pancreatic cancer
5291 (PIK3CB)
05225 Hepatocellular carcinoma
5291 (PIK3CB)
05226 Gastric cancer
5291 (PIK3CB)
05214 Glioma
5291 (PIK3CB)
05221 Acute myeloid leukemia
5291 (PIK3CB)
05220 Chronic myeloid leukemia
5291 (PIK3CB)
05218 Melanoma
5291 (PIK3CB)
05211 Renal cell carcinoma
5291 (PIK3CB)
05215 Prostate cancer
5291 (PIK3CB)
05213 Endometrial cancer
5291 (PIK3CB)
05224 Breast cancer
5291 (PIK3CB)
05222 Small cell lung cancer
5291 (PIK3CB)
05223 Non-small cell lung cancer
5291 (PIK3CB)
09172 Infectious disease: viral
05166 Human T-cell leukemia virus 1 infection
5291 (PIK3CB)
05170 Human immunodeficiency virus 1 infection
5291 (PIK3CB)
05161 Hepatitis B
5291 (PIK3CB)
05160 Hepatitis C
5291 (PIK3CB)
05171 Coronavirus disease - COVID-19
5291 (PIK3CB)
05164 Influenza A
5291 (PIK3CB)
05162 Measles
5291 (PIK3CB)
05168 Herpes simplex virus 1 infection
5291 (PIK3CB)
05163 Human cytomegalovirus infection
5291 (PIK3CB)
05167 Kaposi sarcoma-associated herpesvirus infection
5291 (PIK3CB)
05169 Epstein-Barr virus infection
5291 (PIK3CB)
05165 Human papillomavirus infection
5291 (PIK3CB)
09171 Infectious disease: bacterial
05132 Salmonella infection
5291 (PIK3CB)
05131 Shigellosis
5291 (PIK3CB)
05135 Yersinia infection
5291 (PIK3CB)
05100 Bacterial invasion of epithelial cells
5291 (PIK3CB)
09174 Infectious disease: parasitic
05146 Amoebiasis
5291 (PIK3CB)
05142 Chagas disease
5291 (PIK3CB)
09164 Neurodegenerative disease
05010 Alzheimer disease
5291 (PIK3CB)
05017 Spinocerebellar ataxia
5291 (PIK3CB)
05020 Prion disease
5291 (PIK3CB)
09166 Cardiovascular disease
05417 Lipid and atherosclerosis
5291 (PIK3CB)
05418 Fluid shear stress and atherosclerosis
5291 (PIK3CB)
05415 Diabetic cardiomyopathy
5291 (PIK3CB)
09167 Endocrine and metabolic disease
04930 Type II diabetes mellitus
5291 (PIK3CB)
04932 Non-alcoholic fatty liver disease
5291 (PIK3CB)
04931 Insulin resistance
5291 (PIK3CB)
04933 AGE-RAGE signaling pathway in diabetic complications
5291 (PIK3CB)
09176 Drug resistance: antineoplastic
01521 EGFR tyrosine kinase inhibitor resistance
5291 (PIK3CB)
01524 Platinum drug resistance
5291 (PIK3CB)
01522 Endocrine resistance
5291 (PIK3CB)
09180 Brite Hierarchies
09182 Protein families: genetic information processing
04131 Membrane trafficking [BR:hsa04131]
5291 (PIK3CB)
Enzymes [BR:hsa01000]
2. Transferases
2.7 Transferring phosphorus-containing groups
2.7.1 Phosphotransferases with an alcohol group as acceptor
2.7.1.153 phosphatidylinositol-4,5-bisphosphate 3-kinase
5291 (PIK3CB)
Membrane trafficking [BR:hsa04131]
Endocytosis
Rab GTPases and associated proteins
Rab associated proteins
5291 (PIK3CB)
|
SSDB |
|
Motif |
|
Other DBs |
|
LinkDB |
|
Position |
3:complement(138652698..138834928)
|
AA seq |
1070 aa
MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLW
KQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGE
KLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEH
EPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDE
VSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAI
EAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHG
TELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTI
NPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQ
TNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKE
ILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPK
LPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFL
LERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLK
TLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMD
SKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYG
CLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEE
FTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFIL
TYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKD
IQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS |
NT seq |
3213 nt +upstreamnt +downstreamnt
atgtgcttcagtttcataatgcctcctgctatggcagacatccttgacatctgggcggtg
gattcacagatagcatctgatggctccatacctgtggatttccttttgcccactgggatt
tatatccagttggaggtacctcgggaagctaccatttcttatattaagcagatgttatgg
aagcaagttcacaattacccaatgttcaacctccttatggatattgactcctatatgttt
gcatgtgtgaatcagactgctgtatatgaggagcttgaagatgaaacacgaagactctgt
gatgtcagaccttttcttccagttctcaaattagtgacaagaagttgtgacccaggggaa
aaattagactcaaaaattggagtccttataggaaaaggtctgcatgaatttgattccttg
aaggatcctgaagtaaatgaatttcgaagaaaaatgcgcaaattcagcgaggaaaaaatc
ctgtcacttgtgggattgtcttggatggactggctaaaacaaacatatccaccagagcat
gaaccatccatccctgaaaacttagaagataaactttatgggggaaagctcatcgtagct
gttcattttgaaaactgccaggacgtgtttagctttcaagtgtctcctaatatgaatcct
atcaaagtaaatgaattggcaatccaaaaacgtttgactattcatgggaaggaagatgaa
gttagcccctatgattatgtgttgcaagtcagcgggagagtagaatatgtttttggtgat
catccactaattcagttccagtatatccggaactgtgtgatgaacagagccctgccccat
tttatacttgtggaatgctgcaagatcaagaaaatgtatgaacaagaaatgattgccata
gaggctgccataaatcgaaattcatctaatcttcctcttccattaccaccaaagaaaaca
cgaattatttctcatgtttgggaaaataacaaccctttccaaattgtcttggttaaggga
aataaacttaacacagaggaaactgtaaaagttcatgtcagggctggtctttttcatggt
actgagctcctgtgtaaaaccatcgtaagctcagaggtatcagggaaaaatgatcatatt
tggaatgaaccactggaatttgatattaatatttgtgacttaccaagaatggctcgatta
tgttttgctgtttatgcagttttggataaagtaaaaacgaagaaatcaacgaaaactatt
aatccctctaaatatcagaccatcaggaaagctggaaaagtgcattatcctgtagcgtgg
gtaaatacgatggtttttgactttaaaggacaattgagaactggagacataatattacac
agctggtcttcatttcctgatgaactcgaagaaatgttgaatccaatgggaactgttcaa
acaaatccatatactgaaaatgcaacagctttgcatgttaaatttccagagaataaaaaa
caaccttattattaccctcccttcgataagattattgaaaaggcagctgagattgcaagc
agtgatagtgctaatgtgtcaagtcgaggtggaaaaaagtttcttcctgtattgaaagaa
atcttggacagggatcccttgtctcaactgtgtgaaaatgaaatggatcttatttggact
ttgcgacaagactgccgagagattttcccacaatcactgccaaaattactgctgtcaatc
aagtggaataaacttgaggatgttgctcagcttcaggcgctgcttcagatttggcctaaa
ctgcccccccgggaggccctagagcttctggatttcaactatccagaccagtacgttcga
gaatatgctgtaggctgcctgcgacagatgagtgatgaagaactttctcaatatctttta
caactggtgcaagtgttaaaatatgagccttttcttgattgtgccctctctagattccta
ttagaaagagcacttggtaatcggaggatagggcagtttctattttggcatcttaggtca
gaagtgcacattcctgctgtctcagtacaatttggtgtcatccttgaagcatactgccgg
ggaagtgtggggcacatgaaagtgctttctaagcaggttgaagcactcaataagttaaaa
actttaaatagtttaatcaaactgaatgccgtgaagttaaacagagccaaagggaaggag
gccatgcatacctgtttaaaacagagtgcttaccgggaagccctctctgacctgcagtca
cccctgaacccatgtgttatcctctcagaactctatgttgaaaagtgcaaatacatggat
tccaaaatgaagcctttgtggctggtatacaataacaaggtatttggtgaggattcagtt
ggagtgatttttaaaaatggtgatgatttacgacaggatatgttgacactccaaatgttg
cgcttgatggatttactctggaaagaagctggtttggatcttcggatgttgccttatggc
tgtttagcaacaggagatcgctctggcctcattgaagttgtgagcacctctgaaacaatt
gctgacattcagctgaacagtagcaatgtggctgctgcagcagccttcaacaaagatgcc
cttctgaactggcttaaagaatacaactctggggatgacctggaccgagccattgaggaa
tttacactgtcctgtgctggctactgtgtagcttcttatgtccttgggattggtgacaga
catagtgacaacatcatggtcaaaaaaactggccagctcttccacattgactttggacat
attcttggaaatttcaaatctaagtttggcattaaaagggagcgagtgccttttattctt
acctatgatttcatccatgtcattcaacaaggaaaaacaggaaatacagaaaagtttggc
cggttccgccagtgttgtgaggatgcatatctgattttacgacggcatgggaatctcttc
atcactctctttgcgctgatgttgactgcagggcttcctgaactcacatcagtcaaagat
atacagtatcttaaggactctcttgcattagggaagagtgaagaagaagcactcaaacag
tttaagcaaaaatttgatgaggcgctcagggaaagctggactactaaagtgaactggatg
gcccacacagttcggaaagactacagatcttaa |